Condition: Ulcerative Colitis · Inflammatory Bowel Diseases · Colitis · Sponsor: Spyre Therapeutics, Inc.
This is a Phase 2, multicenter, proof-of-concept platform study in adult participants with moderately to severely active ulcerative colitis (UC). The primary goal of the study is to assess the efficacy and safety of multiple interventions following intravenous (IV) induction and subcutaneous (SC) maintenance treatment.
This description comes directly from the study's public registry record.
SKYLINE-UC Trial Center · 1-650-402-4238 · info@skyline-uc.com
Always discuss trial participation with your own doctor first.
| Site 024 | Canoga Park, California, United States | Recruiting |
| Site 023 | La Jolla, California, United States | Recruiting |
| Site 012 | Lancaster, California, United States | Recruiting |
| Site 033 | Colorado Springs, Colorado, United States | Recruiting |
| Site 007 | Kissimmee, Florida, United States | Recruiting |
| 029 | Miami, Florida, United States | Recruiting |
| Site 038 | Chicago, Illinois, United States | Recruiting |
| Site 006 | Kansas City, Kansas, United States | Recruiting |
| Site 030 | Louisville, Kentucky, United States | Recruiting |
| Site 035 | Marrero, Louisiana, United States | Recruiting |
| Site 011 | Glen Burnie, Maryland, United States | Recruiting |
| Site 003 | Boston, Massachusetts, United States | Recruiting |
+ 247 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07012395